iriomoteolide-1a: from a benthic dinoflagellate amphidinium species; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 16723501 |
| CHEMBL ID | 252951 |
| CHEBI ID | 138823 |
| MeSH ID | M0511052 |
| Synonym |
|---|
| CHEBI:138823 |
| iriomoteolide 1a |
| CHEMBL252951 |
| iriomoteolide-1a |
| C20009 |
| (1s,2r,3e,6s,7r,10z,12r,13s,14e,17s)-1,2,13-trihydroxy-7-[(2s,3s)-3-hydroxy-2-methylbutyl]-2,6,11,12-tetramethyl-19-methylidene-8,21-dioxabicyclo[15.3.1]henicosa-3,10,14-trien-9-one |
| Class | Description |
|---|---|
| macrolide | A macrocyclic lactone with a ring of twelve or more members derived from a polyketide. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID311651 | Cytotoxicity against human DG75 cells | 2007 | Journal of natural products, Oct, Volume: 70, Issue:10 | Iriomoteolides-1b and -1c, 20-membered macrolides from a marine dinoflagellate Amphidinium species. |
| AID311652 | Antiviral activity against EBV in Raji cells | 2007 | Journal of natural products, Oct, Volume: 70, Issue:10 | Iriomoteolides-1b and -1c, 20-membered macrolides from a marine dinoflagellate Amphidinium species. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.13) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 11 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||